Asuragen to Join UK Cancer Research Consortium to Develop miRNA Based Sequencing Tests for Early Detection and Screening of Cancer

January 15, 2015 Leave a comment 2,471 Views

AUSTIN, Texas — Asuragen, Inc., a leading molecular diagnostic company, has been selected to work with the Early Diagnosis Consortium (EDC), a collaboration between Cancer Research UK, Cancer Research Technology, and Abcodia. The Consortium aims to discover and validate serum biomarkers ...

Upcoming Webinar – Next-Generation Sequencing Lessons in Translational Diagnostics

September 4, 2014 Comments Off on Upcoming Webinar – Next-Generation Sequencing Lessons in Translational Diagnostics 3,359 Views

Title – NGS Lessons in Translational Diagnostics: Mining and Migrating Robust Cancer Biomarkers to Unified DNA and RNA NGS Panels Date – September 10, 2014 Time – 1:00pm Eastern Time In this webinar, a comprehensive approach for NGS-based biomarker discovery ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Asuragen

Asuragen to Join UK Cancer Research Consortium to Develop miRNA Based Sequencing Tests for Early Detection and Screening of Cancer

Upcoming Webinar – Next-Generation Sequencing Lessons in Translational Diagnostics

Learning to predict RNA sequence expressions from whole slide images

CRIC-seq – global profiling of in-situ RNA–RNA contacts associated with a specific RNA-binding protein

Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platform

Long noncoding RNA profiling may be effective for stratification in pediatric AML

spSeudoMap – cell type mapping of spatial transcriptomics using unmatched single-cell RNA-seq data

SoCube – an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data

Quantabio adds powerful bead booster chemistry to ultra-fast sparQ RNA-Seq HMR kit